HomeCompareETBI vs QYLD

ETBI vs QYLD: Dividend Comparison 2026

ETBI yields 200000.00% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ETBI wins by $4.911780474428384e+29M in total portfolio value
10 years
ETBI
ETBI
● Live price
200000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.911780474428384e+29M
Annual income
$490,695,411,370,591,700,000,000,000,000,000,000.00
Full ETBI calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — ETBI vs QYLD

📍 ETBI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodETBIQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ETBI + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ETBI pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ETBI
Annual income on $10K today (after 15% tax)
$17,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$417,091,099,665,002,940,000,000,000,000,000,000.00/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, ETBI beats the other by $417,091,099,665,002,940,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ETBI + QYLD for your $10,000?

ETBI: 50%QYLD: 50%
100% QYLD50/50100% ETBI
Portfolio after 10yr
$2.455890237214192e+29M
Annual income
$245,347,705,685,295,860,000,000,000,000,000,000.00/yr
Blended yield
99.90%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ETBI buys
0
QYLD buys
0
No recent congressional trades found for ETBI or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricETBIQYLD
Forward yield200000.00%11.92%
Annual dividend / share$2.00$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.911780474428384e+29M$25.4K
Annual income after 10y$490,695,411,370,591,700,000,000,000,000,000,000.00$5,659.31
Total dividends collected$4.911464459982279e+29M$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: ETBI vs QYLD ($10,000, DRIP)

YearETBI PortfolioETBI Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$20,010,700$20,000,000.00$10,352$1,192.36+$20.00METBI
2$37,424,589,019$37,403,177,570.09$10,830$1,347.57+$37424.58METBI
3$65,416,215,188,220$65,376,170,877,969.18$11,460$1,539.07+$65416215.18METBI
4$106,868,230,495,008,900$106,798,235,144,757,520.00$12,275$1,777.84+$106868230495.00METBI
5$163,172,871,735,896,870,000$163,058,522,729,267,200,000.00$13,323$2,078.95+$163172871735896.88METBI
6$232,854,599,801,468,860,000,000$232,680,004,828,711,460,000,000.00$14,667$2,463.34+$232854599801468864.00METBI
7$310,570,858,137,017,100,000,000,000$310,321,703,715,229,540,000,000,000.00$16,396$2,960.57+$310570858137017057280.00METBI
8$387,148,154,301,613,200,000,000,000,000$386,815,843,483,406,600,000,000,000,000.00$18,631$3,612.97+$3.871481543016132e+23METBI
9$451,061,749,763,281,040,000,000,000,000,000$450,647,501,238,178,360,000,000,000,000,000.00$21,548$4,482.15+$4.510617497632811e+26METBI
10$491,178,047,442,838,440,000,000,000,000,000,000$490,695,411,370,591,700,000,000,000,000,000,000.00$25,398$5,659.31+$4.911780474428384e+29METBI

ETBI vs QYLD: Complete Analysis 2026

ETBIStock

EastGate Biotech Corp. is a pharmaceutical company. The Company produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. It utilizes state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all too often create dangerous side effects and unexpected consequences for those trying to attain and maintain healthy lives. The Company’s products include E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze and Warts X. The Company develops products in which the components are incorporated into vehicles containing nano-sized delivery vectors, including oil droplets (nanoemulsions), polymeric particles (nanoparticles) and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles). It has its offices in New York, London SF, Cockfosters BP, Los Angeles, Chicago and Las Vegas.

Full ETBI Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this ETBI vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ETBI vs SCHDETBI vs JEPIETBI vs OETBI vs KOETBI vs MAINETBI vs XYLDETBI vs JEPQETBI vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.